Caris Life Sciences Inc., a healthcare company devoted to cancer diagnostics and treatment through technological advancements, is taking significant strides toward an Initial Public Offering (IPO) aiming to raise $423.5 million. Supported by investment powerhouse Sixth Street Partners, Caris is set to broaden its impact in the medical sector with this financial maneuver.